A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency

PLoS Pathog. 2018 May 2;14(5):e1007048. doi: 10.1371/journal.ppat.1007048. eCollection 2018 May.

Abstract

The exceptional toxicity of botulinum neurotoxins (BoNTs) is mediated by high avidity binding to complex polysialogangliosides and intraluminal segments of synaptic vesicle proteins embedded in the presynaptic membrane. One peculiarity is an exposed hydrophobic loop in the toxin's cell binding domain HC, which is located between the ganglioside- and protein receptor-binding sites, and that is particularly pronounced in the serotypes BoNT/B, DC, and G sharing synaptotagmin as protein receptor. Here, we provide evidence that this HC loop is a critical component of their tripartite receptor recognition complex. Binding to nanodisc-embedded receptors and toxicity were virtually abolished in BoNT mutants lacking residues at the tip of the HC loop. Surface plasmon resonance experiments revealed that only insertion of the HC loop into the lipid-bilayer compensates for the entropic penalty inflicted by the dual-receptor binding. Our results represent a new paradigm of how BoNT/B, DC, and G employ ternary interactions with a protein, ganglioside, and lipids to mediate their extraordinary neurotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Botulinum Toxins / genetics*
  • Botulinum Toxins / metabolism*
  • Botulinum Toxins, Type A / metabolism
  • Carrier Proteins / metabolism
  • Cell Membrane / metabolism
  • Crystallography, X-Ray
  • Gangliosides
  • Hydrophobic and Hydrophilic Interactions
  • Lipids
  • Membrane Glycoproteins / metabolism
  • Mice
  • Protein Binding
  • Protein Conformation
  • Receptors, Neurotransmitter / metabolism
  • Serogroup
  • Synaptic Vesicles

Substances

  • Carrier Proteins
  • Gangliosides
  • Lipids
  • Membrane Glycoproteins
  • Receptors, Neurotransmitter
  • rimabotulinumtoxinB
  • botulinum toxin type G
  • botulinum toxin type D
  • trisialoganglioside GT1
  • Botulinum Toxins
  • Botulinum Toxins, Type A

Grants and funding

This work was supported by the Bundesministerium für Bildung und Forschung grants FK031A212A to AR (MHH) and FK031A212B to BGD (RKI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.